Award
National Heart, Lung, and Blood Institute 5U24HL153846-05
Randomized Evaluation of Bromocriptine In Myocardial Recovery Therapy for Peripartum Cardiomyopathy (REBIRTH)
Recipient
National Heart Lung and Blood Institute (NHLBI)
Award Amount
$384,826.00
Ceiling
$384,826.00
Awarded
August 15, 2025
Identifier
5U24HL153846-05
NIH grant awarded for a clinical trial on bromocriptine treatment in peripartum cardiomyopathy, with a budget of approximately $385,000 from August 2025 to January 2027.
Description
NIH grant opportunity for a clinical trial evaluating bromocriptine in women with peripartum cardiomyopathy. The project involves data coordination, protocol development, and statistical analysis.